Itacitinib + Everolimus in Hodgkin Lymphoma

NCT03697408 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Classical Hodgkin Lymphoma

Interventions

DRUG: Itacitinib
DRUG: Everolimus

Sponsor

University of Pennsylvania